AMX0035 and Progressive Supranuclear Palsy
Summary
- Eligibility
- for people ages 40-80 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Julio Rojas-Martinez, MD
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Julio Rojas-Martinez, MD
Associate Professor, Neurology, School of Medicine. Authored (or co-authored) 88 research publications. Research interests: Clinical trials · plasma biomarkers · non-pharmacological management
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Amylyx Pharmaceuticals Inc.
- ID
- NCT06122662
- Phase
- Phase 2/3 research study
- Study Type
- Interventional
- Participants
- Expecting 110 study participants
- Last Updated